as salvage therapy in non-hodgkin 's lymphoma ( nhl ) , imv-bleo ( ifosfamide , methotrexate , etoposide , bleomycin ) produced a complete remission ( cr ) rate of 41 % and seemed to be particularly effective in patients with suboptimal response to first-line treatment .
C0024305
non-hodgkin 's lymphoma
C0005740
bleomycin